Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$4,817,048
-$49,149,926 QoQ
Shares Held
18,967
-91.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,646
of 4,676 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OFI INVEST ASSET MANAGEMENT holds $330,320,760 across 8 Drug Manufacturers - General names. JNJ ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
101,109 | $121,273,177 | |
| 2 | MRK |
Merck & Co., Inc.
|
569,512 | $73,182,292 | |
| 3 | ABBV |
AbbVie Inc.
|
274,288 | $69,021,832 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
307,767 | $38,883,282 | |
| 5 | PFE |
Pfizer Inc
|
751,408 | $18,093,904 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
18,967 | $4,817,048 | |
| 7 | AMGN |
Amgen Inc
|
12,932 | $4,682,935 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,357 | $366,290 |
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,817,048 | 18,967 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $53,966,974 | 220,778 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,466,430 | 11,918 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,701,599 | 9,177 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,532,082 | 10,030 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,679,627 | 10,128 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,305,050 | 9,024 | Shares | Sole | 2025-02-07 | |
| 2024-06-30 | $1,462,769 | 10,008 | Shares | Sole | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||